Search
Menu
Home
HTB
2009
February
10
10 February 2009
Contents
Antiretrovirals
EMEA approves once-daily darunavir/ritonavir (800mg/100mg) for treatment-naive patients in Europe
Treatment access
Lost benefit of ARVs in South Africa
HTB RSS
Early access
Long-acting CAB/RPV in people with suboptimal adherence: IMPALA study results at 48 weeks
17 July 2025
Potential for once-monthly oral PrEP using MK-8527
17 July 2025
Five doses a week could be a safe option for adults: crisis response to ART stock-outs
16 July 2025
5-on 2-off dosing is inferior to continuous ART in BREATHER Plus – but no difference in clinical outcomes
16 July 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
AIDS quilts at the Tate: reflection and also anger
8 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate
